Literature DB >> 22581074

Impulse control disorders in Parkinson's disease: a psychosocial perspective.

Mary Delaney1, Iracema Leroi, Jane Simpson, Paul Geoffrey Overton.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease primarily characterised by motor symptoms. However, another feature of PD which is receiving increasing attention is the phenomenon of impulse control disorders (ICDs), such as pathological gambling. To date, research into ICDs in PD has centred on a biomedical model of cause, related to the effects of dopamine replacement therapy. However, there are several areas of discrepancy in the current biomedical account of ICDs in PD. In addition, we argue that social and psychological factors also need to be considered to achieve a more complete understanding of the phenomenon. We present a novel conceptual model which combines biomedical and psychosocial factors in the genesis of ICDs in PD and use the model to identify a number of potential treatment intervention points and to highlight important outstanding questions concerning the inter-relationship between psychosocial and biomedical factors in the genesis of ICDs in PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581074     DOI: 10.1007/s10880-012-9302-7

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  64 in total

Review 1.  Pathophysiology of the basal ganglia in Parkinson's disease.

Authors:  J A Obeso; M C Rodríguez-Oroz; M Rodríguez; J L Lanciego; J Artieda; N Gonzalo; C W Olanow
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

2.  Disabling repetitive behaviors in Parkinson's disease.

Authors:  Roger Kurlan
Journal:  Mov Disord       Date:  2004-04       Impact factor: 10.338

3.  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.

Authors:  Claire Ardouin; Valerie Voon; Yulia Worbe; Nehman Abouazar; Virginie Czernecki; Hassan Hosseini; Antoine Pelissolo; Elena Moro; Eugénie Lhommée; Anthony E Lang; Yves Agid; Alim-Louis Benabid; Pierre Pollak; Luc Mallet; Paul Krack
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

4.  The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

Authors:  James I Hudson; Eva Hiripi; Harrison G Pope; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2006-07-03       Impact factor: 13.382

Review 5.  What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

Authors:  K C Berridge; T E Robinson
Journal:  Brain Res Brain Res Rev       Date:  1998-12

6.  Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease.

Authors:  Angelo Antonini; Chiara Siri; Gabriella Santangelo; Roberto Cilia; Michele Poletti; Margherita Canesi; Alessandra Caporali; Francesca Mancini; Gianni Pezzoli; Roberto Ceravolo; Ubaldo Bonuccelli; Paolo Barone
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

7.  Hypersexuality with antiparkinsonian therapy.

Authors:  R J Uitti; C M Tanner; A H Rajput; C G Goetz; H L Klawans; B Thiessen
Journal:  Clin Neuropharmacol       Date:  1989-10       Impact factor: 1.592

8.  Dopa dose-dependent sexual deviation.

Authors:  N P Quinn; B Toone; A E Lang; C D Marsden; J D Parkes
Journal:  Br J Psychiatry       Date:  1983-03       Impact factor: 9.319

9.  Impulse control disorders in Parkinson disease: a multicenter case--control study.

Authors:  Valerie Voon; Mandy Sohr; Anthony E Lang; Marc N Potenza; Andrew D Siderowf; Jacqueline Whetteckey; Daniel Weintraub; Glen R Wunderlich; Mark Stacy
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

10.  Clinical features associated with impulse control disorders in Parkinson disease.

Authors:  Gregory Pontone; James R Williams; Susan Spear Bassett; Laur Marsh
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

View more
  8 in total

Review 1.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

Review 2.  Neurobiology of gambling behaviors.

Authors:  Marc N Potenza
Journal:  Curr Opin Neurobiol       Date:  2013-03-29       Impact factor: 6.627

3.  Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.

Authors:  Bernd Leplow; Maria Sepke; Robby Schönfeld; Johannes Pohl; Henriette Oelsner; Lea Latzko; Georg Ebersbach
Journal:  J Neural Transm (Vienna)       Date:  2016-11-15       Impact factor: 3.575

4.  The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study.

Authors:  Catharine J Lewis; Franziska Maier; Nina Horstkötter; Carsten Eggers; Veerle Visser-Vandewalle; Elena Moro; Mateusz Zurowski; Jens Kuhn; Christiane Woopen; Lars Timmermann
Journal:  J Neurol       Date:  2014-11-09       Impact factor: 4.849

5.  Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers.

Authors:  David Okai; Sally Askey-Jones; Michael Samuel; Sean S O'Sullivan; K Ray Chaudhuri; Anne Martin; Joel Mack; Richard G Brown; Anthony S David
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

6.  Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.

Authors:  Fahd Baig; Mark J Kelly; Michael A Lawton; Claudio Ruffmann; Michal Rolinski; Johannes C Klein; Thomas Barber; Christine Lo; Yoav Ben-Shlomo; David Okai; Michele T Hu
Journal:  Neurology       Date:  2019-07-16       Impact factor: 9.910

7.  Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson's Disease.

Authors:  Pauline Waskowiak; Vincent Koppelmans; Marit F L Ruitenberg
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 8.  Dopamine Agonists and Impulse Control Disorders: A Complex Association.

Authors:  Marie Grall-Bronnec; Caroline Victorri-Vigneau; Yann Donnio; Juliette Leboucher; Morgane Rousselet; Elsa Thiabaud; Nicolas Zreika; Pascal Derkinderen; Gaëlle Challet-Bouju
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.